New pharmacological therapies to slow the progression of diabetic kidney disease
e-seminar #5
Patient-centred strategies to improving outcomes for people with CKD with and without T2D
Panellists
Hiddo J.L. Heerspink, NL
Katherine Tuttle, USA
Nikolaus Marx, DE
Rajiv Agarwal, USA
Moderators
Kate Stevens, UK
Christoph Wanner, DE
Friday, April 23, 2021 at 5 PM CEST
New York 11 AM / San Francisco 8 AM / Buenos Aires 12 AM / Rio de Janeiro 10 AM / Moscow 6 PM / New Delhi 8.30 PM / Jakarta 10 PM / Beijing 11 PM / Sydney Friday 1 AM
New pharmacological therapies to slow the progression of diabetic kidney disease
e-seminar #4
What is in the new heart failure trials for a nephrologist
Speaker: Per-Henrik Groop, FIN
Panellists:
Beatriz Fernandez-Fernandez, ES
Maria Soler, ES
Niko Marx, DE
Moderated by Christoph Wanner, DE
Friday, February 12, 2021 at 5 PM CET
New York 11 AM / San Francisco 8 AM / Buenos Aires 12 AM / Rio de Janeiro 10 AM / Moscow 6 PM / New Delhi 8.30 PM / Jakarta 10 PM / Beijing 11 PM / Sydney Friday 1 AM
New pharmacological therapies to slow the progression of diabetic kidney disease
e-seminar #3
Mineralocorticoid receptor (MR) antagonist in diabetes kidney disease: results from FIDELIO-DKD study
Speaker: Rajiv Agarwal, USA
External Panellists:
Michael Burnier, CH
Peter Rossing, DK
Maria Soler, ES
Annette Bruchfeld, SWE
Moderated by Kate Stevens, UK
Thursday January 21, 2021 at 5 PM CET
New York 11 AM / San Francisco 8 AM / Buenos Aires 12 AM / Rio de Janeiro 10 AM / Moscow 6 PM / New Delhi 8.30 PM / Jakarta 10 PM / Beijing 11 PM / Sydney Friday 1 AM
New pharmacological therapies to slow the progression of diabetic kidney disease
e-seminar #2
New guidelines to optimize the clinical care of people with diabetes and CKD
Panellists
Speaker: Ian De Boer, USA
External Panellist: Katherine Tuttle, USA
Moderated by Christoph Wanner, D
Thursday January 14, 2021 at 4 PM CET
New York 10 AM / San Francisco 7 AM / Buenos Aires 11 AM / Rio de Janeiro 9 AM / Moscow 5 PM / New Delhi 7.30 PM / Jakarta 9 PM / Beijing 10 PM / Sydney Friday 12 AM
New pharmacological therapies to slow the progression of diabetic kidney disease
e-seminar #1
SGLT2- inhibitors and CKD patients: drugs for everyone?
Panellists
Christoph Wanner, Nephrologist, D
Hiddo J.L. Heerspink, Clinical Pharmacologist, NL
Gert Mayer, Nephrologist, A
Moderated by Kate Stevens, Nephrologist, UK
Please send questions to education@era-edta.org
Thursday October 15, 2020 at 4 PM BST/5 PM CEST
New York 11 AM / San Francisco 8 AM / Buenos Aires 12 AM / Rio de Janeiro 10 AM / Moscow 6 PM / New Delhi 8.30 PM / Jakarta 10 PM / Beijing 11 PM / Sydney Friday 1 AM
